AstraZeneca AZN-1.07%decrease; red down pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...

At AstraZeneca, we win through science. It’s at the heart of every success. The game changer in our mission to turn ideas into life-changing medicines that improve patient health and society.

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge, said to be the biggest science lab of its kind in the UK. The Discovery Centre ...

The new facility in Cambridge will house around 1,000 employees and will be next to its existing £1.1 billion research and development centre on the city's biomedical campus.

CAMBRIDGE, England, April 29, 2025--AstraZeneca: Revenue and EPS summary. News. Today's news; US; Politics ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA.

CAMBRIDGE, England, November 12, 2024--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...

Article ‘Count’ and ‘Share’ for AstraZeneca Cambridge based on listed parameters only. According to the parameters selected above, there are no articles from AstraZeneca Cambridge from 1 ...

AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company ...